Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study

Abstract Introduction We aim to assess the association of patient-reported pain and remission or low disease activity (LDA) at 3 months (M) in patients receiving baricitinib or other treatments in RA-BE-REAL. Methods RA-BE-REAL reports on patients with rheumatoid arthritis (RA) who were prescribed,...

Full description

Bibliographic Details
Published in:Rheumatology and Therapy
Main Authors: Peter C. Taylor, Walid Fakhouri, Samuel Ogwu, Ewa Haladyj, Inmaculada de la Torre, Bruno Fautrel, Rieke Alten, Peter Nash, Eugen Feist
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-12-01
Subjects:
Baricitinib
Rheumatoid arthritis
Remission
Low disease activity
Online Access:https://doi.org/10.1007/s40744-024-00732-8

Internet

https://doi.org/10.1007/s40744-024-00732-8

Similar Items